Invention Grant
- Patent Title: Compounds useful for inhibiting RORγt
-
Application No.: US16482577Application Date: 2018-02-27
-
Publication No.: US11008336B2Publication Date: 2021-05-18
- Inventor: Christian Alexander Clarke , Charles Willis Lugar, III , John Richard Morphy , Timothy Ivo Richardson , Helene Rudyk , Selma Sapmaz , Ryan Edward Stites , Grant Mathews Vaught
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Nelsen L Lentz
- International Application: PCT/US2018/019920 WO 20180227
- International Announcement: WO2018/160550 WO 20180907
- Main IPC: C07D495/20
- IPC: C07D495/20 ; A61K45/06 ; A61P29/00
Abstract:
The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof, formula (A).
Public/Granted literature
- US20200048279A1 COMPOUNDS USEFUL FOR INHIBITING ROR-GAMMA-T Public/Granted day:2020-02-13
Information query
